ID   HChol-Y1
AC   CVCL_M256
DR   Wikidata; Q54881878
RX   CelloPub=CLPUB00275;
RX   PubMed=2989602;
RX   PubMed=35640676;
CC   Group: Serum/protein free medium cell line.
CC   Population: Japanese.
CC   Doubling time: 52 hours (PubMed=2989602).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
RX   CelloPub=CLPUB00275;
RA   Zach S., Birgin E., Ruckert F.;
RT   "Primary cholangiocellular carcinoma cell lines.";
RL   J. Stem Cell Res. Transplant. 2:1013-1013(2015).
//
RX   PubMed=2989602; DOI=10.1093/jnci/75.1.29;
RA   Yamaguchi N., Morioka H., Ohkura H., Hirohashi S., Kawai K.;
RT   "Establishment and characterization of the human cholangiocarcinoma
RT   cell line HChol-Y1 in a serum-free, chemically defined medium.";
RL   J. Natl. Cancer Inst. 75:29-35(1985).
//
RX   PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007;
RA   Isidan A., Yenigun A., Soma D., Aksu E., Lopez K., Park Y.,
RA   Cross-Najafi A., Li P., Kundu D., House M.G., Chakraborty S.,
RA   Glaser S., Kennedy L., Francis H., Zhang W.-J., Alpini G.D., Ekser B.;
RT   "Development and characterization of human primary cholangiocarcinoma
RT   cell lines.";
RL   Am. J. Pathol. 192:1200-1217(2022).
//